Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

GRANULES's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.

Financial Ratios:

currentRatio 1.277000
forwardPE 19.159037
debtToEquity 45.369000
earningsGrowth 0.342000
revenueGrowth 0.342000
grossMargins 0.612870
operatingMargins 0.158990
trailingEps 22.490000
forwardEps 29.490000

GRANULES's current ratio 1.277, suggesting the company has sufficient liquidity to service its short-term debt. With its cash reserves and current assets in good shape, GRANULES can comfortably meet its immediate liabilities, reflecting a healthy financial standing.
GRANULES's Forward PE is at a healthy level, indicating that the stock price is well-positioned relative to its earnings. With the stock not being overvalued, there remains room for future growth, suggesting a balanced opportunity for investors seeking potential upside.
GRANULES's positive earnings and revenue growth reflect an optimistic outlook for the company's future. The growth in these key areas indicates that GRANULES is expected to continue expanding its business and boosting its financial performance in the coming periods.
Granules India Limited's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that Granules India Limited's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

GRANULES's price projections have been revised upward over time, suggesting that analysts are becoming more confident in the company's future. This trend points to increased optimism about GRANULES's ability to grow.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


Analysts' buy bias for GRANULES signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to GRANULES, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.